Christine Bii

Christine Bii

Auto-generated profile, based on publicly available information

Christine Bii

Mycology Division, Center for Microbiology Research, Kenya Medical Research Institute, Nairobi P.O. Box 54840 00200, Kenya

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
Martha MushiMartha Mushi
Martha Mushi
CMConjester Isdory Mtemisika
Conjester Isdory Mtemisika
OBOliver Bader
Oliver Bader
CBChristine Bii
Christine Bii
MMMariam Mirambo
Mariam Mirambo
SMStephen E. Mshana
Stephen E. Mshana
Non-albicans Candida (NAC) spp. in immunocompromised patients are linked to invasive infections with narrow treatment choice. This study aimed at comparing the oral colonization of NAC spp. between HIV and non-HIV infected individuals in Mwanza, Tanzania. Oral rinse of 351 HIV-infected and 639 non-HIV infected individuals were collected between March and July 2015. Phenotypic identifications of Candida spp. was done using Candida Chromogenic agar and confirmed by MALDI-TOF MS. NAC spp. were detected in 36/351 (10.3%) HIV-infected individuals compared to 28/639 (4.4%) of non-HIV infected individuals; P=0.0003. In HIV infected individuals, commonly isolated NAC spp. were Candida tropicalis, 10(2.8%), C. krusei (Issatschenki orientalis) 9(2.6%) and C. glabrata 8(2.3%). While for non-HIV infected individuals C. dubliniensis 8(1.3%) and C. tropicalis 5(0.9%) were commonly detected. As CD4 count/μl decreases by one unit the risk of being colonized by NAC spp. among HIV infected individuals increases by 1% (OR 1.01, 95% CI; 1.001-1.004, P=0.001). The prevalence of NAC spp. is high among HIV-infected individuals with low CD4 count placing them at higher risk of invasive infections. Further studies to investigate the role of NAC spp. in causing invasive infections among immunocompromised patients are recommended.

25 September 2015 in Mycoses
Verified
Journal Article
Closed access
PDF file
MKMourine Kangogo
Mourine Kangogo
OBOliver Bader
Oliver Bader
HBHamadi Boga
Hamadi Boga
WWWanjiru Wanyoike
Wanjiru Wanyoike
CFClaudia Folba
Claudia Folba
CBChristine C. Bii
Christine C. Bii

27 July 2010 in African Journal of Traditional, Complementary and Alternative Medicines
Verified
Journal Article
Open access
PDF file
CMC Mutai
C Mutai
CBC Bii
C Bii
GRG Rukunga
G Rukunga
JOJ Ondicho
J Ondicho
PMP Mwitari
P Mwitari
JKJ Kirui
J Kirui
Acacia mellifera has been used widely in traditional African medicines against various diseases. Among the Kipsigis community of Kenya, water extracts from the plant is used for the treatment of skin diseases, coughs and gastrointestinal ailments. The aim of the study was to provide scientific rationale for the use of the plant in traditional medicine through bioassay-guided fractionation of A. mellifera stem bark. Bioactivity testing was done against selected microbes using disc diffusion technique as outlined in Clinical Laboratory Standard Institute (CLSI). Structure elucidation of the isolated compounds was based primarily on 1D and 2D NMR analyses, including HMQC, HMBC, and NOESY correlations. Fractionation yielded three triterpenoids; (20S)-oxolupane-30- al, (20R)-oxolupane-30-al, and betulinic acid. The three compounds were active against Staphylococcus aureus ATCC 25923 and only (20S)-oxolupane-30-al against clinical isolate of Microsporum gypseum. The three compounds had no activity against Escherichia coli ATCC 25922, Enterococcus feacalis, Candida albicans ATCC 90028, Cryptococcus neoformans, Trichophyton mentagrophyte, Candida krusei, Microsporum gypseum, and Sacharomyces cerevisiae. These results explain and support the use of A. mellifera stem barks for the treatment of infectious diseases in traditional Kenya medicine.It also shows that the antimicrobial activity is concentrated in the triterpenoid fractions. Keywords: Acacia mellifera; Antimicrobial pentacyclic triterpenes; Kenya medicinal plant.

24 November 2020 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
ABAbebe Bizuye
Abebe Bizuye
LGLashitew Gedamu
Lashitew Gedamu
CBChristine Bii
Christine Bii
EGErastus Gatebe
Erastus Gatebe
NMNaomi Maina
Naomi Maina
Infectious diseases caused by antibiotic-resistant bacteria lead to a considerable increase in human morbidity and mortality globally. This requires to search potential actinomycete isolates from undiscovered habitats as a source of effective bioactive metabolites and to synthesis metabolite-mediated antibacterial silver nanoparticles (AgNPs). The main purpose of the present study was to identify actinomycetes isolated from Thika waste dump soils that produce bioactive metabolites to synthesize antibacterial AgNPs. The synthesis of metabolite-mediated AgNP was confirmed with visual detection and a UV-vis spectrophotometer, whereas the functional groups involved in AgNP synthesis were identified using a FTIR spectrophotometer. The antibacterial activity of the metabolite-mediated AgNPs was tested by a well diffusion assay. Identification of actinomycete isolates involved in the synthesis of antibacterial AgNPs was done based on 16S rRNA gene sequence analysis. The visual detection showed that dark salmon and pale golden color change was observed due to the formation of AgNPs by KDT32 and KGT32 metabolites, respectively. The synthesis was confirmed by a characteristic UV spectra peak at 415.5nm for KDT32-AgNP and 416nm for KGT32-AgNP. The FTIR spectra revealed that OH, C=C, and S-S functional groups were involved in the synthesis of KDT32-AgNP, whereas OH, C=C, and C-H were involved in the formation of KGT32-AgNP. The inhibition zone results revealed that KDT32-AgNP showed 22.0±1.4mm and 19.0±1.4mm against Escherichia coli and Salmonella typhi, whereas KGT32-AgNP showed 21.5±0.7mm and 17.0±0.0mm, respectively. KDT32 and KGT32 isolates were identified as genus Streptomyces and their 16S rRNA gene sequences were deposited in the GenBank database with MH301089 and MH301090 accession numbers, respectively. Due to the bactericidal activity of synthesized AgNPs, KDT32 and KGT32 isolates can be used in biomedical applications.

1 January 2023 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
GGGebreselema Gebreyohannes
Gebreselema Gebreyohannes
DSDesta B. Sbhatu
Desta B. Sbhatu
DNDr. KIMANGA A. Nyerere
Dr. KIMANGA A. Nyerere
CBChristine Bii
Christine Bii
AGAbrha Gebreselema Gebrehiwot
Abrha Gebreselema Gebrehiwot
Objective. This study was aimed at determining the antioxidant, anti‐quorum sensing, and in vitro cytotoxic activities of five wild mushroom extracts. Methods. Wild mushrooms of Auricularia auricula-judae, Termitomyces umkowaani, Trametes elegans, Trametes versicolor, and Microporus xanthopus were collected from Arabuko‐Sokoke and Kakamega National Forests, in Kenya. Specimens were identified and extracted using chloroform (CHL), 70% ethanol (Eth), and hot water (HW) solvents. Antioxidant and cytotoxic activities of the extracts were determined using 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) and Vero cell lines, respectively, while anti‐quorum sensing activities were tested against Chromobacterium violaceum. All data were compared using relevant descriptive and inferential statistics at a significance level of p ≤ 0.05. Results. A total of 35 wild mushrooms were collected, identified, and classified into 14 genera. Among screened mycochemicals, fatty acids, flavonoids, polyphenols, and saponins were detected at higher concentrations. The highest free radical scavenging activities of A. auricula-judae, T. umkowaani, T. elegans, and T. versicolor were observed in 70% Eth extract with the percentage values of 76.40 ± 0.12%, 68.40 ± 0.01%, 62.40 ± 0.07%, and 66.40 ± 0.04%, respectively, whereas the HW extract of Microporus xanthopus showed free radical scavenging activity at 65.90 ± 0.02%. None of the extracts, at the tested concentrations (up to 1000 µg/mL), had shown cytotoxic activity against the Vero cell line. The HW extract of T. umkowaani and the 70% Eth extract of T. versicolor showed a statistically significant difference in the inhibitory activity of violacein production against C. violaceum at the concentration of 200 µg/mL. Conclusions. The antioxidant activity of wild mushrooms can help to tackle the diseases caused by free radicals. The anti‐quorum sensing potential of wild mushrooms could also provide future alternatives to conventional drug therapies cost‐effectively. Further detailed chemistry of the bioactive compounds and their possible mechanisms of action responsible for the observed antioxidant and anti‐quorum sensing activities are needed.

30 March 2022 in Grasas y Aceites
Verified
Journal Article
Open access
PDF file
HRH.K. Ruto
H.K. Ruto
JYJ.O. Yugi
J.O. Yugi
SOS.O. Ochanda
S.O. Ochanda
CBC. Bii
C. Bii
The polyphenolic composition and antioxidant activity of tea seed oil from C. sinensis TRFK 301/5 (green colored) and TRFK 306 (purple colored) and C. oleifera were evaluated. The total polyphenolic content, total catechins and catechin fractions were significantly different in the oils. C. oleifera contained significantly (p ≤ 0.05) higher amounts of catechins and polyphenols than C. sinensis. C. oleifera also exhibited a higher DPPH radical scavenging activity (18.81 ± 0.46%) compared to C. sinensis (TRFK 306; 15.98 ± 0.13 and TRFK 301/5; 14.73 ± 0.47%). The antimicrobial activities of tea seed oil and two selected oils (olive and eucalyptus oil), were also evaluated against Escherichia coli, Staphylococcus aureus, Candinda albicans, Cryptococcus neoformans and Trichophyton mentagrophytes. S. aureus was significantly inhibited by the oils compared to E. coli. The oils inhibited the growth of T. mentagrophytes and C. albicans, although they had no effect on C. neoformans. Tea seed oil is a potential source of beneficial phytochemicals and potent antimicrobial agents.